Logo Bayernportal

Medicinal products; retrieval of published assessment reports

On the portal for medicinal product information of the federal and state governments, you can view public assessment reports with information on the approval decision for medicinal products as a supplement to the information for healthcare professionals and package leaflets.

Online services & Forms

Online services

Responsible for you

Bundesinstitut für Arzneimittel und Medizinprodukte

Street address

Kurt-Georg-Kiesinger-Allee 3
53175 Bonn

Postal address

Kurt-Georg-Kiesinger-Allee 3

53175 Bonn

Website

www.bfarm.de

Procedure details

In the so-called public assessment reports (PAR), the Federal Institute for Drugs and Medical Devices (BfArM) informs users, for example

  • Doctors,
  • pharmacists and
  • other healthcare professionals.

The PARs contain information on medicinal products and medical devices regarding

  • Quality,
  • efficacy,
  • safety or
  • risks, such as areas of application and possible side effects.

The PARs are intended to contain all essential information for the authorization decision and are a supplement to the already publicly available information for healthcare professionals and package leaflets.

The assessment reports published by the BfArM refer to medicinal products for human use. They are published on the portal for medicinal product information of the federal and state governments (online platform PharmNet.Bund).

You can view these assessment reports there at any time.

There are no prerequisites.

  • Required Documents

    Sie müssen keine Unterlagen einreichen.

  • Open the online platform PharmNet.Bund.
  • Click on "Drug Information System" and then on "Search".
  • Once you have accepted the declaration of consent, you can search for medicinal products and also read the assessment reports.

There are no costs for you.

You do not have to meet any deadlines.

The BfArM publishes the PAR promptly after authorization of the corresponding medicinal products. In the event of major changes to the authorization, for example indication extensions, the BfArM publishes updates promptly. The time required for preparation depends, among other things, on the complexity of the authorized medicinal product.

The publication of the public assessment reports does not constitute an appealable decision.

Status: 09.03.2025
Editorially responsible for prodecure description: Bundesministerium für Gesundheit
Source: Federal Portal
Contains machine translated content. Show the original content